NCT07726082 Micro-choice-based Intervention for Multicausal Fatigue
| NCT ID | NCT07726082 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Multicausal Fatigue |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2026-08 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2026-08 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This proof-of-concept study aims to evaluate the feasibility, acceptability, and potential benefits of a novel multimodal approach: the micro-choice-based intervention.
Eligibility Criteria
Inclusion Criteria: * Experiencing persistent fatigue with a significant impact on daily functioning (Chalder Fatigue- Scale bimodal ≥ 4) Exclusion Criteria: * Have insufficient proficiency in German to complete study-related questionnaires * Lack the cognitive capacity to understand study procedures (e.g. due to dementia) * Present with severe medical conditions that may interfere with participation (e.g., advanced organ failure, uncontrolled inflammatory or autoimmune diseases, or severe psychiatric disorders) * Have active cancer or are currently undergoing cancer treatment * Are deemed incompatible with group participation during the preparation phase, based on a team assessment. Reasons for exclusion based on group incompatibility include: (-Need for a level of individual therapeutic support that exceeds what can be provided in a group setting; -Refusal to engage in group-based therapy; -Personality traits that are considered incompatible with group dynamics; -Failure to attend the mandatory preparatory webinar (no-show is considered a no-go); -Other significant reasons as determined by the therapeutic team)
Contact & Investigator
Katrin Bopp, Dr.
PRINCIPAL INVESTIGATOR
University Hospital, Basel, Switzerland
Frequently Asked Questions
Who can join the NCT07726082 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Multicausal Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07726082 currently recruiting?
Yes, NCT07726082 is actively recruiting participants. Contact the research team at katrin.bopp@usb.ch for enrollment information.
Where is the NCT07726082 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT07726082 clinical trial?
NCT07726082 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Katrin Bopp, Dr. at University Hospital, Basel, Switzerland. The trial plans to enroll 24 participants.